Difficulty: Medium
Average Score: 91%
Practice
Tumor lysis syndrome is a common complication during treatment of pediatric malignancies. Which malignancy is more likely to manifest such complication?
Correct answer
D
Rationale
Tumor lysis syndrome (TLS) is a potentially life-threatening complication that can occur during the treatment of malignancies due to the rapid breakdown of cancer cells leading to metabolic imbalances. In pediatric oncology, Burkitt lymphoma is more likely to manifest TLS compared to other malignancies listed.
Burkitt lymphoma is a highly proliferative and fast-growing cancer, characterized by rapid cell turnover. When treatment is initiated, the massive destruction of tumor cells can overwhelm the body's ability to clear the metabolic byproducts, leading to TLS. This is why option D (Burkitt lymphoma) is the correct answer.
The other options can be eliminated as they are less commonly associated with TLS in pediatric patients. Acute myelogenous leukemia (AML) and nephroblastoma are not typically linked to TLS due to differences in their pathophysiology and cell turnover rates. Neuroblastoma, although it can cause tumor lysis, is less likely to result in TLS compared to Burkitt lymphoma due to differences in tumor burden and cell turnover dynamics.
Understanding which malignancies are more prone to TLS is crucial for pediatric nurses caring for oncology patients. Recognizing the predisposing factors can help in early identification, prompt management, and prevention of TLS-related complications, ultimately improving patient outcomes.
Burkitt lymphoma is a highly proliferative and fast-growing cancer, characterized by rapid cell turnover. When treatment is initiated, the massive destruction of tumor cells can overwhelm the body's ability to clear the metabolic byproducts, leading to TLS. This is why option D (Burkitt lymphoma) is the correct answer.
The other options can be eliminated as they are less commonly associated with TLS in pediatric patients. Acute myelogenous leukemia (AML) and nephroblastoma are not typically linked to TLS due to differences in their pathophysiology and cell turnover rates. Neuroblastoma, although it can cause tumor lysis, is less likely to result in TLS compared to Burkitt lymphoma due to differences in tumor burden and cell turnover dynamics.
Understanding which malignancies are more prone to TLS is crucial for pediatric nurses caring for oncology patients. Recognizing the predisposing factors can help in early identification, prompt management, and prevention of TLS-related complications, ultimately improving patient outcomes.